Journal profile · PEDIATRICS-RHEUMATOLOGY
Pediatric Rheumatology
ISSN 1546-0096 · BioMed Central · England · Irregular · Founded 2007
Pediatric Rheumatology: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 2.26; fully open access; APC about USD 3,190; median 100 days to acceptance (98 articles, last 24 months); community-reported acceptance: easy; 133 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Pediatric Rheumatology is published by BioMed Central and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Autoimmune and Inflammatory Disorders Research, Inflammasome and immune disorders and Adolescent and Pediatric Healthcare, together about 44.3% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Pediatric Rheumatology is the official publication of the Pediatric Rheumatology European Society (PReS). Submissions on the evaluation and treatment of non-surgical musculoskeletal syndromes and diseases in children and adolescents, particularly autoimmune and rheumatic diseases are welcomed. Diseases and syndromes of particular interest include musculoskeletal pain syndromes, rheumatic fever and post-streptococcal syndromes, juvenile idiopathic arthritis, systemic lupus erythematosus, juvenile dermatomyositis, local and systemic scleroderma, Kawasaki disease, Henoch-Schonlein purpura and other vasculitides, sarcoidosis, inherited musculoskeletal syndromes, autoinflammatory syndromes, and others. Pediatric Rheumatology encourages submissions on educational advances, drug studies, laboratory and radiological evaluations, and outcome measures.
From the journal's Aims & Scope
Research area (LetPub): PEDIATRICS-RHEUMATOLOGY
Editor-in-chief Tadej AvcPublisher website
Editorial board by country: 4 in mainland China (about 4%); most named United States 19, Italy 9, United Kingdom 8, Canada 7, Netherlands 6 (93 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Autoimmune and Inflammatory Disorders ResearchMedicine23.4%
- Inflammasome and immune disordersBiochemistry, Genetics and Molecular Biology11.2%
- Adolescent and Pediatric HealthcareHealth Professions9.6%
- Rheumatoid Arthritis Research and TherapiesMedicine8.7%
- Systemic Lupus Erythematosus ResearchMedicine7%
- Ocular Diseases and Behçet’s SyndromeMedicine3.3%
- Kawasaki Disease and Coronary ComplicationsMedicine3.2%
- Vasculitis and related conditionsMedicine3%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Pediatrics | Zone 2 |
| Minor | Rheumatology | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Pediatrics | Zone 3 |
| Minor | Rheumatology | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Pediatrics | Zone 3 |
| Minor | Rheumatology | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEEmbaseCASPublisher website
Other: Google Scholar, ProQuest, Dimensions, CNKI, Baidu, Naver, OCLC, Portico, CLOCKSS, Semantic Scholar
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.26LetPub ·
- Impact factor (publisher) 2025
- 2.3Publisher website ·
- 5-year impact factor (publisher) 2025
- 2.8Publisher website ·
- CiteScore 2026-06
- 4LetPub ·
- SJR 2026-06
- 0.82LetPub ·
- SNIP 2026-06
- 1.12LetPub ·
- h-index
- 30LetPub ·
- h-index
- 76OpenAlex ·
- i10-index
- 911OpenAlex ·
- 2-year mean citedness
- 2.32OpenAlex ·
- Self-citation rate
- 4.3%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 122LetPub ·
- Downloads per year (publisher) 2025
- 1,900,000Publisher website ·
Articles by year OpenAlex count · 3,801 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 90 | 90 | 10 |
| 2025 | 133 | 133 | 273 |
| 2024 | 120 | 120 | 514 |
| 2023 | 144 | 144 | 1,202 |
| 2022 | 121 | 121 | 1,496 |
| 2021 | 173 | 173 | 3,306 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
100 daysMedian, submission to acceptance · P25–P75 82 days – 142 days
- Acceptance to online
- median 18 days (98 articles)
- Submission to online
- median 121 days
- Sample
- 98 articles with submission and acceptance dates (248 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- over 12 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
- Submission to first decision
- 11 daysPublisher website ·
- Submission to publication (journal-reported)
- about 17 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | EUR 2,690 / USD 3,190 / GBP 2,390 | Yes | CC BY, CC BY-NC-ND | |
| OpenAlex | USD 3,090 / EUR 2,590 / GBP 2,290 | — | — | |
| LetPub | GBP 2,090 / USD 2,890 / EUR 2,390 | Yes | — | |
| Publisher website | Yes, amount not published | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Open calls for papers1, by deadline
Publisher websiteExcerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- BioMed Central
- Country or region
- England
- Language
- English
- Frequency
- Irregular
- Founded
- 2007
- ISSN
- 1546-0096
- Society / sponsor
- Paediatric Rheumatology European Society
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Pediatric Rheumatology
What CAS zone is Pediatric Rheumatology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Pediatric Rheumatology is in Zone 3 of Medicine, and in Zone 2 of the minor category Pediatrics / Rheumatology. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Pediatric Rheumatology?
The latest impact factor listed by LetPub is 2.26; CiteScore 4, h-index 76.
How long does peer review take at Pediatric Rheumatology?
Based on the dates recorded on 98 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 100 days (interquartile range 82–142 days); authors report an average review time of over 12 weeks; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Pediatric Rheumatology based?
Of the 93 board members whose country the journal's board page names, 4 (about 4%) are in mainland China; the countries named most often are United States (19), Italy (9) and United Kingdom (8). Counted from the institutions listed on the board page; for reference only.
Which databases index Pediatric Rheumatology?
According to LetPub and DOAJ records, Pediatric Rheumatology is indexed in SCIE, Scopus and DOAJ. The journal's website also lists MEDLINE, Embase and CAS; that list has not been checked against each database.
Is Pediatric Rheumatology open access, and what is the APC?
Pediatric Rheumatology is a fully open-access journal. APC about USD 3,190.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .